Physician profile
Michael Sand
NPI 1932552148
$1,069.45
in general payments reported to CMS, 2019-2025
10 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2021: $11.36 · 2023: $140 · 2024: $349 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.93 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $332.42 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $145.54 | 2021-2025 | Xywav |
| Harmony Biosciences LLC | $137.69 | 2023-2025 | Wakix |
| Sanofi-Aventis U.S. LLC | $120.96 | 2019 | |
| Abbvie INC. | $119.48 | 2019 | |
| Csl Behring | $99.47 | 2019 | |
| Resmed Corp | $54.94 | 2023-2024 | |
| Axsome Therapeutics, INC. | $26.93 | 2024 | Sunosi |
| Lilly USA, LLC | $18.76 | 2025 | Zepbound |
| Amgen INC. | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.